US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 0.694
  • +0.018+2.65%
Close Dec 20 16:00 ET
  • 0.708
  • +0.014+1.97%
Post 20:01 ET
62.87MMarket Cap-0.38P/E (TTM)

About Verrica Pharmaceuticals Company

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Company Profile

SymbolVRCA
Company NameVerrica Pharmaceuticals
Listing DateJun 15, 2018
Issue Price15.00
Founded2013
CEODr. Jayson Rieger
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
Address44 West Gay Street,Suite 400
CityWest Chester
ProvincePennsylvania
CountryUnited States of America
Zip Code19380
Phone1-434-453-3300
Websitehttp://www.verrica.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jayson Rieger
  • Director, Chief Executive Officer and President
  • --
  • John J. Kirby
  • Interim Chief Financial Officer and Interim Principal Accounting Officer
  • --
  • Gary Goldenberg
  • Chief Medical Officer
  • --
  • Christopher G. Hayes
  • Chief Legal Officer
  • 2.56M
  • David Zawitz
  • Chief Operating Officer
  • --
  • Paul B. Manning
  • Chairman of the Board
  • --
  • Sean Stalfort
  • Director
  • --
  • Dr. Lawrence Eichenfield, M.D.
  • Independent Director
  • 119.19K
  • Dr. Diem Nguyen, M.B.A.,PhD
  • Independent Director
  • 99.19K
  • Mark A. Prygocki, Sr
  • Independent Director
  • 119.19K
Heat List
US
Overall
Symbol
Price
% Chg

No Data